Showing results (491-500 of 502) with videos related to
Sort By:
Pageof 51
Biomolecules|August 6, 2021
COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?Kenneth Lundstrom, Debmalya Barh, Bruce D Uhal, et al.Journal of the American Society of Nephrology : JASN|January 1, 2013
DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GNFatih Ozaltin, Binghua Li, Alysha Rauhauser, et al.Archives of Biochemistry and Biophysics|January 27, 2022
The importance of accessory protein variants in the pathogenicity of SARS-CoV-2Sk Sarif Hassan, Pabitra Pal Choudhury, Guy W Dayhoff, et al.Computers in Biology and Medicine|April 19, 2021
A unique view of SARS-CoV-2 through the lens of ORF8 proteinSk Sarif Hassan, Alaa A A Aljabali, Pritam Kumar Panda, et al.The Lancet. Neurology|March 21, 2015
Neuroinflammation in Alzheimer's diseaseMichael T Heneka, Monica J Carson, Joseph El Khoury, et al.Cell Death and Differentiation|December 13, 2017
Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseasesNiamh M C Connolly, Pierre Theurey, Vera Adam-Vizi, et al.Cell Death and Differentiation|April 18, 2009
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotesL Galluzzi, S A Aaronson, J Abrams, et al.Cell Death and Differentiation|September 20, 2014
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015L Galluzzi, J M Bravo-San Pedro, I Vitale, et al.Cell Death and Differentiation|January 25, 2018
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018Lorenzo Galluzzi, Ilio Vitale, Stuart A Aaronson, et al.Cell Death and Differentiation|April 26, 2023
Apoptotic cell death in disease-Current understanding of the NCCD 2023Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.Pageof 51